CNTO 3157

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CNTO 3157, covering 2012-11-27 to 2014-12-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CNTO 3157 in Healthy Normal and Asthmatic Participants Inoculated With Human Rhinovirus Type 16 [Phase 1]

See pricing